BioNTech SE (BNTX)
85.04
-2.61
(-2.98%)
USD |
NASDAQ |
Nov 12, 16:00
84.66
-0.38
(-0.45%)
After-Hours: 06:39
BioNTech Total Assets (Quarterly) : 22.91B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 22.91B |
| June 30, 2026 | 23.26B |
| March 31, 2026 | 24.28B |
| December 31, 2025 | 25.82B |
| September 30, 2025 | 25.08B |
| June 30, 2025 | 25.40B |
| March 31, 2025 | 22.88B |
| December 31, 2024 | 23.33B |
| September 30, 2024 | 25.00B |
| June 30, 2024 | 23.83B |
| March 31, 2024 | 24.04B |
| December 31, 2023 | 25.41B |
| September 30, 2023 | 23.51B |
| June 30, 2023 | 24.25B |
| Date | Value |
|---|---|
| March 31, 2023 | 23.99B |
| December 31, 2022 | 24.84B |
| September 30, 2022 | 22.20B |
| June 30, 2022 | 22.12B |
| March 31, 2022 | 22.59B |
| December 31, 2021 | 18.00B |
| September 30, 2021 | 16.49B |
| June 30, 2021 | 10.85B |
| March 31, 2021 | 4.942B |
| December 31, 2020 | 2.837B |
| September 30, 2020 | 1.699B |
| June 30, 2020 | 1.093B |
| March 31, 2020 | 803.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Moderna, Inc. | 13.47B |
| Mereo BioPharma Group Plc | 29.58M |
| NuCana Plc | 34.22M |
| Immatics NV | 642.58M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.797B |
| Shareholders Equity (Quarterly) | 20.12B |
| Debt to Equity Ratio | 0.0286 |
| Current Ratio | 8.552 |
| Net Debt Paydown Yield | -0.21% |